Director Analytics Systems
Beacon Biosignals
Director Analytics Systems
Beacon Biosignals
EEG neurobiomarker platform for trials
Beacon Biosignals is transforming precision medicine for the brain, from clinical development to clinical care. For Life Sciences partners, we offer the leading at-home EEG platform for clinical development of novel therapeutics for neurological, psychiatric, and sleep disorders. Our Diagnostics business is building the most comprehensive at-home platform for precision diagnostics, combining EEG and cardiopulmonary signals to deliver reimbursable assessments for sleep and central nervous system disorders. Together, we're changing the way patients are diagnosed and treated for any disorder that affects brain physiology.
Beacon Biosignals is seeking a Director, Analytics Systems to manage our Analytics Systems Team. The Analytics System Team is responsible for building and maintaining Beacon’s Analytics Suite products that serve our Life Sciences and Diagnostic customers, developing tooling and pipelines that enable Beacon scientists to efficiently curate clinical trial data and perform rigorous scientific analyses, and enabling the scalable computation, organization, and tracking of novel biomarker features. This includes evolving our data infrastructure to support a centralized feature store and integrating foundation models into our core analytical pipelines. In this role, you'll manage 6-10 engineers and will be responsible for the continued development and success of your team and its products. This role reports directly to Beacon's VP of Analytics and Machine Learning.
Beacon's robust asynchronous work practices ensure a first-class remote work experience, but we also have in-person office hubs available located in Boston, New York, and Paris. The Analytics Systems Team is currently distributed across American time zones.
EEG neurobiomarker platform for trials
Beacon Biosignals develops an EEG-based neurobiomarker platform for precision medicine in neurology and psychiatry. Its core offering provides quantitative assessments of how treatments affect EEG and sleep data to speed up clinical trials and inform dose selection. By analyzing EEG signals alongside PK/PD relationships, the platform helps identify dosing that achieves the best balance of efficacy and safety, supporting the development of new therapies. The company differentiates itself through its proprietary EEG biomarkers and a focus on integrating brain activity data into trial design, enabling closer monitoring of treatment impact for biopharma, academic medical centers, and neurotechnology developers. Beacon Biosignals aims to advance personalized treatment for neurological and psychiatric diseases and improve the efficiency of clinical development in precision medicine.
Explore more opportunities at Beacon Biosignals